COCP — Cocrystal Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Annual balance sheet for Cocrystal Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	7.42	33	58.7	37.1	26.4
Net Total Accounts Receivable
Net Total Receivables	0.644	0.556	0	0.716	0.89
Prepaid Expenses
Total Other Current Assets
Total Current Assets	8.28	34	59.3	40.2	29.1
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.11	1.09	0.931	0.616	2.12
Net Goodwill
Long Term Investments
Total Assets	28.5	54.2	79.4	40.8	31.3
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2.29	1.36	1.54	1.22	3.26
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	2.82	1.74	1.84	1.27	4.88
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	25.7	52.5	77.5	39.6	26.4
Total Liabilities & Shareholders' Equity	28.5	54.2	79.4	40.8	31.3
Total Common Shares Outstanding